PODCAST
Your Dentist Might Know Something About Your Bones Before Your Doctor Does
October 5, 2026·9:12·Episode 138
Quick Summary
This episode covers three research papers relevant to postmenopausal health: a Chinese study on whether a DNA-based cervical screening test performs differently after menopause, a clarification on a vitamin D drug used for bone thinning, and a cross-sectional study on whether dental imaging can flag low bone density before a formal bone scan is ever ordered.
Your Dentist Might Know Something About Your Bones Before Your Doctor Does
0:000:00
Key Takeaways
- ✦A DNA methylation test used for cervical screening (PAX1/JAM3) appears to perform differently in postmenopausal women than in premenopausal women — which matters for how results should be read and acted on.
- ✦Eldecalcitol, a stronger vitamin D drug used in some Asian countries for postmenopausal bone thinning, is not the same as the vitamin D supplement on your shelf — the distinction matters when reading research about it.
- ✦A type of dental X-ray called a CBCT scan can estimate bone density in the jaw, and this study found meaningful overlap with formal bone density scores (DEXA T-scores) — a possible early-detection signal that most dental visits don't flag.
- ✦The CBCT-bone density connection is cross-sectional and preliminary — it shows an association, not a proven screening tool. Researchers are not saying "skip the DEXA."
- ✦All three studies are observational or retrospective, conducted primarily in Asian populations, and need replication before changing clinical practice in other groups.
Sources & References
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.